A PHASE-I STUDY OF SURAMIN (SUR) IN PATIENTS WITH ADVANCED CANCER (CA)

被引:0
|
作者
KOBAYASHI, K [1 ]
VOKES, EE [1 ]
JANISCH, L [1 ]
PARKS, C [1 ]
VOGELZANG, NJ [1 ]
RATAIN, MJ [1 ]
机构
[1] UNIV CHICAGO,HEMATOL ONCOL SECT,CHICAGO,IL 60637
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [21] PHASE-I STUDY OF INDICINE N-OXIDE IN PATIENTS WITH ADVANCED CANCER
    OHNUMA, T
    SRIDHAR, KS
    RATNER, LH
    HOLLAND, JF
    CANCER TREATMENT REPORTS, 1982, 66 (07): : 1509 - 1515
  • [22] PHASE-I PHASE-II STUDY OF SURAMIN IN HORMONE RESISTANT METASTATIC PROSTATE-CANCER
    VANRIJSWIJK, REN
    VANLOENEN, AC
    HORENBLAS, S
    WAGSTAFF, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 185 - 185
  • [23] A PHASE-I TRIAL OF WEEKLY LOMUSTINE IN PATIENTS WITH ADVANCED CANCER
    KOLLER, CA
    GORSKI, CC
    BENJAMIN, RS
    LEGHA, SS
    PAPADOPOULOS, NE
    PLAGER, C
    CANCER, 1994, 73 (01) : 236 - 239
  • [24] PHASE-I STUDY OF 4-DEMETHOXYDAUNORUBICIN BY ORAL ROUTE IN PATIENTS WITH ADVANCED CANCER
    KRARUPHANSEN, A
    ANDERSEN, E
    ELBAEK, K
    RASMUSSEN, SN
    DALMARK, M
    ACTA ONCOLOGICA, 1988, 27 (05) : 521 - 525
  • [25] PHASE-I STUDY OF RECOMBINANT HUMAN INTERFERON-BETA IN PATIENTS WITH ADVANCED CANCER
    HU, E
    HORNING, SJ
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (02): : 121 - 129
  • [26] A phase-I study of the combination of intravenous reovirus (REOLYSIN ®) and gemcitabine in patients with advanced cancer
    Lolkema, M. P.
    Harrington, K.
    Evans, J.
    Arkenau, H. T.
    Roxburgh, P.
    Morrison, R.
    Roulstone, V.
    Coffey, M.
    Mettinger, K.
    de Bono, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 131 - 131
  • [27] A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer
    Ryan, CW
    Vokes, EE
    Vogelzang, NJ
    Janisch, L
    Kobayashi, K
    Ratain, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (01) : 1 - 5
  • [28] A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer
    Christopher W. Ryan
    Everett E. Vokes
    Nicholas J. Vogelzang
    Linda Janisch
    Ken Kobayashi
    Mark J. Ratain
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 1 - 5
  • [29] PHASE-I STUDIES OF RTNF-ALPHA IN PATIENTS WITH ADVANCED CANCER
    GABRILOVE, JL
    STARNES, HF
    BEGAS, A
    CASPER, E
    CHAPMAN, P
    ENGERT, A
    JAKUBOWSKI, A
    TEMPLETON, MA
    SHERWIN, S
    BRENNAN, M
    OETTGEN, HF
    IMMUNOBIOLOGY, 1987, 175 (1-2) : 12 - 13
  • [30] PHASE-I AND CLINICAL PHARMACOLOGIC EVALUATION OF LONIDAMINE IN PATIENTS WITH ADVANCED CANCER
    YOUNG, CW
    CURRIE, VE
    KIM, JH
    OHEHIR, MA
    FARAG, FM
    KINAHAN, JE
    ONCOLOGY, 1984, 41 : 60 - 65